Condition: HIV Infected Individuals · HIV · Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Autologous CAR-T cell therapy in HIV-1/AIDS patients
This description comes directly from the study's public registry record.
Xiao Wang, D.Eng · +86 22 2746 8129 · wangx21@mails.tsinghua.edu.cn
Xuanling Shi, MD · shixuanlingsk@mail.tsinghua.edu.cn
Always discuss trial participation with your own doctor first.
| Chinese Academy of Medical Sciences Hospital of Hematology (Chinese Academy of Medical Sciences Institute of Hematology), Tianjin, 300020 | Tianjin, Tianjin Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06880380